Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Deferiprone

An oral iron chelator, first approved in 1994, in the European Union in 1999 and in the United States in 2011, to remove excess iron in patients with thalassaemia major. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?The captured iron leaves the body in the urine: that is why one of the most common effects is red-brown urine, a visible sign that iron is being removed.

DeferiproneGo to the active ingredient →
DeferiproneActive ingredientDeferiproneCat. No. P-D032-001CAS 30652-11-0
Deferiprone-d3Isotopically labelledDeferiprone-d3Cat. No. P-D032-006CAS 1346601-82-8

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.